From the Department of Emergency Medicine (D.A.T., G.J.M.); Division of Infectious Diseases (D.A.T., G.J.M.), Department of Medicine; Department of Surgery (D.J.S.), Olive View-UCLA Medical Center, Sylmar; and Department of Surgery (D.A.D.), Division of Pediatric Surgery, Harbor-UCLA Medical Center, Torrance, California.
J Trauma Acute Care Surg. 2019 Apr;86(4):722-736. doi: 10.1097/TA.0000000000002137.
Meta-analyses and a recent guideline acknowledge that conservative management of uncomplicated appendicitis with antibiotics can be successful for patients who wish to avoid surgery. However, guidance as to specific management does not exist.
PUBMED and EMBASE search of trials describing methods of conservative treatment was conducted according to Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines.
Thirty-four studies involving 2,944 antibiotic-treated participants were identified. The greatest experience with conservative treatment is in persons 5 to 50 years of age. In most trials, imaging was used to confirm localized appendicitis without evidence of abscess, phlegmon, or tumor. Antibiotics regimens were generally consistent with intra-abdominal infection treatment guidelines and used for a total of 7 to 10 days. Approaches ranged from 3-day hospitalization on parenteral agents to same-day hospital or ED discharge of stable patients with outpatient oral antibiotics. Minimum time allowed before response was evaluated varied from 8 to 72 hours. Although pain was a common criterion for nonresponse and appendectomy, analgesic regimens were poorly described. Trials differed in use of other response indicators, that is, white blood cell count, C-reactive protein, and reimaging. Diet ranged from restriction for 48 hours to as tolerated. Initial response rates were generally greater than 90% and most participants improved by 24 to 48 hours, with no related severe sepsis or deaths. In most studies, appendectomy was recommended for recurrence; however, in several, patients had antibiotic retreatment with success.
While further investigation of conservative treatment is ongoing, patients considering this approach should be advised and managed according to study methods and related guidelines to promote informed shared decision-making and optimize their chance of similar outcomes as described in published trials. Future studies that address biases associated with enrollment and response evaluation, employ best-practice pain control and antibiotic selection, better define cancer risk, and explore longer time thresholds for response, minimized diet restriction and hospital stays, and antibiotic re-treatment will further our understanding of the potential effectiveness of conservative management.
Systematic review, level II.
荟萃分析和最近的指南都承认,对于希望避免手术的单纯性阑尾炎患者,采用抗生素的保守治疗是可行的。然而,具体的管理方法尚不存在。
根据系统评价和荟萃分析的首选报告项目,对描述保守治疗方法的试验进行了 PUBMED 和 EMBASE 搜索。
确定了 34 项涉及 2944 名接受抗生素治疗的参与者的研究。在大多数试验中,影像学用于确认没有脓肿、蜂窝织炎或肿瘤证据的局部阑尾炎。抗生素方案通常与腹腔内感染治疗指南一致,总疗程为 7 至 10 天。治疗方法从 3 天的静脉用抗生素住院治疗到稳定患者的当天住院或急诊科出院,并给予门诊口服抗生素。从开始治疗到评估反应的最短时间从 8 小时到 72 小时不等。虽然疼痛是判断无反应和阑尾切除术的常见标准,但镇痛药方案描述不佳。试验在其他反应指标的使用上存在差异,即白细胞计数、C 反应蛋白和重新成像。饮食从 48 小时限制到耐受为止。初始反应率通常大于 90%,大多数参与者在 24 至 48 小时内得到改善,没有相关的严重脓毒症或死亡。在大多数研究中,建议对复发患者进行阑尾切除术;然而,在几项研究中,患者成功地进行了抗生素再治疗。
虽然对保守治疗的进一步研究正在进行中,但应根据研究方法和相关指南向考虑这种方法的患者提供建议和管理,以促进知情的共同决策,并优化他们在已发表试验中描述的类似结果的机会。未来的研究如果能够解决与入组和反应评估相关的偏倚,采用最佳的疼痛控制和抗生素选择,更好地定义癌症风险,探索更长的反应时间阈值,减少饮食限制和住院时间,并进行抗生素再治疗,将进一步加深我们对保守管理潜在有效性的理解。
系统评价,二级。